Squadron Capital Management LLC Hedge Fund

CIK: 0002050709 · Show all filings

Period: Q4 2025

Filing Date: Feb 17, 2026

Total Value ($000): $235,971 (100.0% shares, 0.0% debt)

Holdings (33)

RLMD RELMADA THERAPEUTICS INC 13.7%
Value ($000) $32,361 Shares 6,700,000 Est. Cost $3.35 Unrealized 0.0%
COGT COGENT BIOSCIENCES INC 11.7%
Value ($000) $27,706 Shares 780,000 Est. Cost $28.11 Unrealized 0.0%
MAZE MAZE THERAPEUTICS INC 8.6%
Value ($000) $20,301 Shares 490,000 Est. Cost $34.37 Unrealized 0.0%
ABVX ABIVAX SA 8.3%
Value ($000) $19,554 Shares 145,000 Est. Cost $134.85 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 4.8%
Value ($000) $11,305 Shares 700,000 Est. Cost $13.24 Unrealized 0.0%
PALI PALISADE BIO INC 4.5%
Value ($000) $10,575 Shares 4,500,000 Est. Cost $1.92 Unrealized 0.0%
EWTX EDGEWISE THERAPEUTICS INC 3.7%
Value ($000) $8,685 Shares 350,000 Est. Cost $20.07 Unrealized 0.0%
IKT INHIBIKASE THERAPEUTICS INC 3.7%
Value ($000) $8,661 Shares 4,225,000 Est. Cost $1.59 Unrealized 0.0%
KOD KODIAK SCIENCES INC 3.5%
Value ($000) $8,156 Shares 291,710 Est. Cost $20.48 Unrealized 0.0%
TERN TERNS PHARMACEUTICALS INC 3.3%
Value ($000) $7,676 Shares 190,000 Est. Cost $23.11 Unrealized 0.0%
AVBP ARRIVENT BIOPHARMA INC 2.9%
Value ($000) $6,801 Shares 338,000 Est. Cost Unrealized
TARS TARSUS PHARMACEUTICALS INC 2.8%
Value ($000) $6,550 Shares 80,000 Est. Cost $74.67 Unrealized 0.0%
UPB UPSTREAM BIO INC 2.7%
Value ($000) $6,262 Shares 230,650 Est. Cost $24.89 Unrealized 0.0%
SPRB SPRUCE BIOSCIENCES INC 2.6%
Value ($000) $6,098 Shares 70,000 Est. Cost $107.14 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 2.0%
Value ($000) $4,731 Shares 105,551 Est. Cost $42.00 Unrealized 0.0%
DBVT DBV TECHNOLOGIES S A 1.9%
Value ($000) $4,601 Shares 240,000 Est. Cost $19.17 Unrealized
HELP CYBIN INC 1.8%
Value ($000) $4,295 Shares 525,000 Est. Cost $6.44 Unrealized 0.0%
LPCN LIPOCINE INC NEW 1.8%
Value ($000) $4,256 Shares 530,000 Est. Cost $3.36 Unrealized 0.0%
BLTE BELITE BIO INC 1.8%
Value ($000) $4,159 Shares 26,000 Est. Cost $159.96 Unrealized
GHRS GH RESEARCH PLC 1.7%
Value ($000) $4,001 Shares 315,000 Est. Cost $13.62 Unrealized 0.0%
EPRX EUPRAXIA PHARMACEUTICALS INC 1.6%
Value ($000) $3,775 Shares 500,000 Est. Cost $6.16 Unrealized 0.0%
VTYX VENTYX BIOSCIENCES INC 1.6%
Value ($000) $3,702 Shares 410,000 Est. Cost $7.47 Unrealized 0.0%
NXTC NEXTCURE INC 1.4%
Value ($000) $3,363 Shares 236,966 Est. Cost $10.36 Unrealized 0.0%
VERA VERA THERAPEUTICS INC 1.3%
Value ($000) $3,038 Shares 60,000 Est. Cost Unrealized
WVE WAVE LIFE SCIENCES LTD 1.3%
Value ($000) $2,975 Shares 175,000 Est. Cost $10.16 Unrealized 0.0%
KTTA PASITHEA THERAPEUTICS CORP 1.1%
Value ($000) $2,709 Shares 2,100,000 Est. Cost $0.88 Unrealized 0.0%
CMPS COMPASS PATHWAYS PLC 1.1%
Value ($000) $2,679 Shares 388,287 Est. Cost $6.90 Unrealized
AVTX AVALO THERAPEUTICS INC 1.0%
Value ($000) $2,361 Shares 130,000 Est. Cost $16.88 Unrealized 0.0%
IVA INVENTIVA SA 0.6%
Value ($000) $1,395 Shares 300,000 Est. Cost $4.65 Unrealized
ZBIO ZENAS BIOPHARMA INC 0.6%
Value ($000) $1,307 Shares 36,000 Est. Cost Unrealized
TRAW TRAWS PHARMA INC 0.3%
Value ($000) $806 Shares 713,540 Est. Cost $2.22 Unrealized 0.0%
NTLA INTELLIA THERAPEUTICS INC 0.3%
Value ($000) $728 Shares 81,000 Est. Cost Unrealized
CLYM CLIMB BIO INC 0.2%
Value ($000) $400 Shares 100,000 Est. Cost $2.40 Unrealized 0.0%